tiprankstipranks
Safety Shot (SHOT)
NASDAQ:SHOT
US Market

Safety Shot (SHOT) Stock Price & Analysis

641 Followers

SHOT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.25 - $7.50
Previous Close$2.02
Volume43.99K
Average Volume (3M)1.40M
Market Cap
$95.98M
Enterprise Value$96.82M
Total Cash (Recent Filing)$4.68M
Total Debt (Recent Filing)$2.07M
Price to Earnings (P/E)-4.3
Beta0.84
May 13, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares Outstanding49,220,273
10 Day Avg. Volume803,345
30 Day Avg. Volume1,403,588
Standard Deviation0.47
R-Squared0.04
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)11.56
Price to Sales (P/S)-25.86
Price to Cash Flow (P/CF)-4.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue143.43
Enterprise Value/Gross Profit-1.30K
Enterprise Value/Ebitda-12.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

13.77%1.86%1.15%83.23%
13.77% Insiders
1.15% Other Institutional Investors
83.23% Public Companies and Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

SHOT FAQ

What was Safety Shot’s price range in the past 12 months?
Safety Shot lowest stock price was $0.25 and its highest was $7.50 in the past 12 months.
    What is Safety Shot’s market cap?
    Currently, no data Available
    When is Safety Shot’s upcoming earnings report date?
    Safety Shot’s upcoming earnings report date is May 13, 2024 which is in 10 days.
      How were Safety Shot’s earnings last quarter?
      Safety Shot released its earnings results on Apr 01, 2024. The company reported -$0.145 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.145.
        Is Safety Shot overvalued?
        According to Wall Street analysts Safety Shot’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Safety Shot pay dividends?
          Safety Shot pays a Notavailable dividend of $0.21 which represents an annual dividend yield of N/A. See more information on Safety Shot dividends here
            What is Safety Shot’s EPS estimate?
            Safety Shot’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Safety Shot have?
            Safety Shot has 49,220,272 shares outstanding.
              What happened to Safety Shot’s price movement after its last earnings report?
              Safety Shot reported an EPS of -$0.145 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.531%.
                Which hedge fund is a major shareholder of Safety Shot?
                Currently, no hedge funds are holding shares in SHOT
                ---

                Safety Shot Stock Smart Score

                Company Description

                Safety Shot

                Jupiter Wellness Inc is a wellness hemp-derived cannabidiol, consumer product development company. It is engaged in manufacturing, distributing, and marketing of consumer products infused with CBD. Its products include CaniSun, CaniSkin and CaniDermRX. Under the CaniSun brand name.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Medical Marijuana
                CNBX Pharmaceuticals
                CV Sciences
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis